Skip to main content
. Author manuscript; available in PMC: 2008 Jun 11.
Published in final edited form as: Oral Oncol. 2007 Sep 6;44(1):10–22. doi: 10.1016/j.oraloncology.2007.06.011

Table 5.

Problems with studies of toluidine blue

  • No studies carried out in a primary care environment

  • Data from studies in secondary care are not necessarily applicable to general population

  • No randomized controlled trials

  • Some studies only include carcinomas or dysplasia and some include both

  • Histological diagnosis is rarely used as a gold standard

  • Methods vary – single rinse, double rinse, ‘painting’

  • Confusion over inclusion of equivocal (pale) staining as positive or negative.